News Researcher and industry join forces to unravel and treat autism

12 July 2018

In a large public-private project, supported by 110 million euros by the IMI, a large consortium of researchers will search for biomarkers with which people with autism can be divided into clear subgroups.

Such stratification increases the chance of effective treatments. The Radboud UMC is also involved in the huge project. In 2012 the large European autism research EU-AIMS started. This abbreviation stands for European Autism Interventions - a Multicenter Study for Developing New Medications. The project, which ended at the end of March of this year, has immediately received a successor: AIMS-2. This new project builds on the results that the first program has produced.
 

Public-private project

The main applicant for AIMS-2 is the British King's College in London, but the researchers at Donders Institute and Radboudumc are also important partners in the project. Professor of psychiatry Jan Buitelaar is co-leader of clinical studies, Professor of Statistical Imaging Neuroscience Christian Beckmann leads the development of new statistical techniques and databases. The public-private project has been awarded by the European IMI, the Innovative Medicines Initiative. With the pharmaceutical companies that participate, the research institutes received a total of 110 million euros to unravel the Autism Spectrum Disorder (AAS) in detail and on that basis develop medication for the various subgroups that fall under ASD.

Related news items


VSB Scholarships for studying or doing research abroad

16 November 2018

For those of you who have supervised or will supervise students who finish their BSc or MSc between 1-3-2018 and 31-12-2019.

read more

Sepsis-associated acute kidney injury: A randomized clinical trial

15 November 2018

Peter Pickkers, theme Infectious diseases and global health, published in JAMA, that among patients who were critically ill with sepsis-associated acute kidney injury, human recombinant alkaline phosphatase compared with placebo did not significantly improve short-term kidney function.

read more

EMUC first prize poster on bladder cancer for Alina Vrieling

15 November 2018

Alina Vrieling received the first prize for the best unmoderated poster on Bladder Cancer at the 10th European Multidisciplinary Congress on Urological Cancers (EMUC).

read more

Regenerative medicine could treat fecal incontinence, in the future

15 November 2018

Wiep de Lingy and Alejandra Ruiz-Zapata, theme Reconstructive and regenerative medicine, systematically reviewed preclinical and clinical studies looking into regenerative medicine strategies to treat fecal incontinence in a recent publication in the American Journal of Obstetrics and Gynecology.

read more

Large NWO grant for Chris de Korte

15 November 2018

NWO Domain Applied and Engineering Sciences (AES) has granted project ULTRA-X-TREME 4 million euros for developing new 3D ultrasound techniques allowing patient-specific diagnosis of vascular problems and prevention of unnecessary operations.

read more

€ 100k grant to investigate relation between bruxism and tooth wear

13 November 2018

The research proposal 'Bruxism and tooth wear: a destructive combination?' of Bas Loomans and Stanimira Kalaykova has received a research grant of € 100k on the occasion of the 125th anniversary of the ‘Nederlands Tijdschrift voor Tandheelkunde (NTvT)’

read more
  • Go to